文献速递哮喘

新型机器学习可预测急性哮喘加重

Novel Machine Learning Can Predict Acute Asthma Exacerbation.
PubMed 文献 · Chest · 2021-01-10

该研究基于克利夫兰诊所2010至2018年60,302例哮喘患者电子健康记录,构建逻辑回归、随机森林和梯度提升决策树模型预测非重度加重、急诊就诊和住院。轻量梯度提升机预测性能最佳,曲线下面积分别为0.71、0.88和0.85。年龄、长效β受体激动剂、高剂量吸入糖皮质激素或长期口服糖皮质激素为共同风险因素。

要点

  • 轻量梯度提升机预测哮喘急诊就诊和住院的AUC达0.88和0.85。
  • 年龄、LABA、高剂量ICS或长期OCS为三类结局共同风险因素。
  • 加入肺功能检查未提升模型预测性能。

核心结论

  • 基于真实世界门诊电子健康记录的机器学习模型能较准确预测哮喘加重,可整合入临床决策工具。

研究设计与样本

  • 回顾性队列分析,纳入克利夫兰诊所2010至2018年60,302例哮喘患者电子健康记录数据。
  • 预测结局为非重度加重需口服糖皮质激素冲击、急诊就诊和住院。
  • 构建逻辑回归、随机森林和梯度提升决策树三种模型。

主要发现

  • 19,772例(32.8%)发生至少一次非重度加重需口服糖皮质激素冲击。
  • 1,748例(2.9%)需急诊就诊,902例(1.5%)需住院。
  • 轻量梯度提升机预测非重度加重、急诊就诊和住院的AUC分别为0.71(95%CI 0.70-0.72)、0.88(95%CI 0.86-0.89)和0.85(95%CI 0.82-0.88)。
  • 年龄、长效β受体激动剂、高剂量吸入糖皮质激素或长期口服糖皮质激素为所有三种结局的风险因素。
  • 在9,448例有肺功能数据的亚组中,低FEV1和FEV1/FVC比为加重、急诊就诊和住院的顶级风险因素,但加入肺功能检查未改善模型预测性能。

临床怎么用

  • 可利用电子健康记录数据构建机器学习模型辅助门诊哮喘患者风险分层。
  • 对具有年龄、LABA、高剂量ICS或长期OCS等风险因素的患者可加强监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Asthma exacerbations result in significant health and economic burden, but are difficult to predict. RESEARCH QUESTION: Can machine learning (ML) models with large-scale outpatient data predict asthma exacerbations? STUDY DESIGN AND METHODS: We analyzed data extracted from electronic health records (EHRs) of asthma patients treated at the Cleveland Clinic from 2010 through 2018. Demographic information, comorbidities, laboratory values, and asthma medications were included as covariates. Three different models were built with logistic regression, random forests, and a gradient boosting decision tree to predict: (1) nonsevere asthma exacerbation requiring oral glucocorticoid burst, (2) ED visits, and (3) hospitalizations. RESULTS: Of 60,302 patients, 19,772 (32.8%) had at least one nonsevere exacerbation requiring oral glucocorticoid burst, 1,748 (2.9%) requiring and ED visit and 902 (1.5%) requiring hospitalization. Nonsevere exacerbation, ED visit, and hospitalization were predicted best by light gradient boosting machine, an algorithm used in ML to fit predictive analytic models, and had an area under the receiver operating characteristic curve of 0.71 (95% CI, 0.70-0.72), 0.88 (95% CI, 0.86-0.89), and 0.85 (95% CI, 0.82-0.88), respectively. Risk factors for all three outcomes included age, long-acting β agonist, high-dose inhaled glucocorticoid, or chronic oral glucocorticoid therapy. In subgroup analysis of 9,448 patients with spirometry data, low FEV1 and FEV1 to FVC ratio were identified as top risk factors for asthma exacerbation, ED visits, and hospitalization. However, adding pulmonary function tests did not improve models' prediction performance. INTERPRETATION: Models built with an ML algorithm from real-world outpatient EHR data accurately predicted asthma exacerbation and can be incorporated into clinical decision tools to enhance outpatient care and to prevent adverse outcomes.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Zein JG, Wu CP, Attaway AH, et al. Novel Machine Learning Can Predict Acute Asthma Exacerbation. Chest. 2021. PMID: 33440184. doi:10.1016/j.chest.2020.12.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。